Nebulization of monoclonal antibodies for treating pulmonary diseases

Details for Australian Patent Application No. 2006243994 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Yi, Wang

Agent Shelston IP

Pub. Number AU-B-2006243994

PCT Pub. Number WO2006/122257

Priority 11/127,438 11.05.05 US

Filing date 10 May 2006

Wipo publication date 16 November 2006

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

13 December 2007 PCT application entered the National Phase

  PCT publication WO2006/122257 Priority application(s): WO2006/122257

1 March 2012 Application Accepted

  Published as AU-B-2006243994

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006244012-Expandable resins

2006243987-Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof